Kangmei Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 1,143.95 million compared to CNY 933.85 million a year ago. Revenue was CNY 1,143.95 million compared to CNY 933.85 million a year ago.

Net loss was CNY 50.41 million compared to CNY 111.42 million a year ago. Basic loss per share from continuing operations was CNY 0.004 compared to CNY 0.008 a year ago. Diluted loss per share from continuing operations was CNY 0.004 compared to CNY 0.008 a year ago.